cell and gene therapy pipeline 2

https://stemcelltherapyresearchdaily.alderbrief.com/posts/how-a-stem-cell-therapy-research-digest-keeps-you-informed-on-regenerative-medicine

Our cell and gene therapy pipeline is advancing rapidly, with several candidates moving toward clinical trials. We're focusing on engineered CAR-T cells for blood cancers and next-generation gene editing for rare inherited disorders. Each program targets specific patient needs, from improving treatment durability to reducing side effects. It's a complex but exciting frontier, and we're committed to seeing these therapies through.